Abstract:Contrast-enhanced ultrasound has shown convincing results for monitoring vessel morphology, surrogate markers of vascularization and changes in molecular marker expression in oncological and cardiovascular diseases. Ultrasound contrast agents have the ability to increase the backscattering signal intensity of an ultrasound pulse. An interesting class of ultrasound contrast agents are gas filled microbubbles, which can be synthesized by external bubble encapsulation using sugar matrices or microspheres consisting of lipids or polymers with or without surfactant and by selecting gases with low blood solubility and diffusion coefficient such as perfluorocarbons or sulphur hexafluoride. Ultrasound contrast agents can be classified according to the rigidity of their shell. Soft-shell microbubbles are coated with a thin monolayer of surfactant molecules such as palmitic acid or phospholipids and are very sensitive to pressure changes. Hard-shell microbubbles have a rigid shell made of polymers such as polycyanoacrylate, which dramatically increases their stability. Depending on the acoustic properties of the microbubbles and on the purpose of the examination either destructive or non destructive methods are preferred for their detection. Microbubbles can be detected by destructive and non-destructive methods. Both soft- and hard-shell microbubbles coated with target-specific molecules can also be used for molecular imaging. Using target-specific approaches, the expression of several angiogenic markers such as VEGFR2, alphavbeta3 Integrins, ICAM, and E-selectin has been investigated in neoplastic and vascular diseases. This article summarizes the synthesis and properties of contrast agents as well as the indications, limitations and future potential of contrast-enhanced functional and molecular ultrasound.

Ultrasound microbubble contrast agents: Application to therapy for peripheral vascular disease

PrEPArAtION OF A tHErAPEUtIc ULtrAsOUND cONtrAst AGENt Composition of a Microbubble Components of a Microbubble Shell

Research of Ultrasound-Mediated Gene Delivery

Microbubbles and ultrasound: from diagnosis to therapy

Nano/Microparticles And Ultrasound Contrast Agents

Development and New Clinical Applications of Ultrasound Microbubble Contrast Agents

Application of Ultrasound Microbubbles in Cardiovascular Diseases

Biogenic Gas Vesicles for Ultrasound Imaging and Targeted Therapeutics

Introduction of Ultrasound Microbubble Technology Aided Tumor Imaging and Treatment

Encapsulated ultrasound microbubbles: Therapeutic application in drug/gene delivery

Progress and preclinical application status of ultrasound microbubbles

Use of Cationic Microbubbles Targeted to P-selectin to Improve Ultrasound-Mediated Gene Transfection of Hvegf165 to the Ischemic Myocardium

Vascular Gene Transfer and Drug Delivery in Vitro Using Low-Frequency Ultrasound and Microbubbles

Microsphere as a contrast agent/gene vector in ultrasound imaging-based vascular gene delivery

Ultrasound Microbubbles for Diagnosis and Treatment of Cardiovascular Diseases

Ultrasound-mediated diagnostic imaging and advanced treatment with multifunctional micro/nanobubbles.

Ultrasound-mediated Diagnostic Imaging and Advanced Treatment with Multifunctional Micro/nanobubbles

Ultrasound Microbubbles for Molecular Diagnosis, Therapy, and Theranostics

Ultrasound-mediated targeted microbubbles: a new vehicle for cancer therapy

Functional and Molecular Ultrasound Imaging: Concepts and Contrast Agents

Advances in Molecular Targeted Ultrasound Contrast Agents